Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP385855.RAwScJUU_KEjZlbFpv98_noJW7tOeD7ZabrTaipQwlFhU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP385855.RAwScJUU_KEjZlbFpv98_noJW7tOeD7ZabrTaipQwlFhU130_assertion type Assertion NP385855.RAwScJUU_KEjZlbFpv98_noJW7tOeD7ZabrTaipQwlFhU130_head.
- NP385855.RAwScJUU_KEjZlbFpv98_noJW7tOeD7ZabrTaipQwlFhU130_assertion wasGeneratedBy ECO_0000203 NP385855.RAwScJUU_KEjZlbFpv98_noJW7tOeD7ZabrTaipQwlFhU130_provenance.
- NP385855.RAwScJUU_KEjZlbFpv98_noJW7tOeD7ZabrTaipQwlFhU130_assertion wasDerivedFrom befree-2016 NP385855.RAwScJUU_KEjZlbFpv98_noJW7tOeD7ZabrTaipQwlFhU130_provenance.
- NP385855.RAwScJUU_KEjZlbFpv98_noJW7tOeD7ZabrTaipQwlFhU130_assertion SIO_000772 12619114 NP385855.RAwScJUU_KEjZlbFpv98_noJW7tOeD7ZabrTaipQwlFhU130_provenance.
- NP385855.RAwScJUU_KEjZlbFpv98_noJW7tOeD7ZabrTaipQwlFhU130_assertion evidence source_evidence_literature NP385855.RAwScJUU_KEjZlbFpv98_noJW7tOeD7ZabrTaipQwlFhU130_provenance.
- NP385855.RAwScJUU_KEjZlbFpv98_noJW7tOeD7ZabrTaipQwlFhU130_assertion description "[Specific emphasis is placed on genetic alterations and the prevalence of TP53 (p53) gene alterations in the distinct biological ovarian tumors (benign, borderline, and malignant) and histological subtypes (serous, mucinous, endometrioid, clear cell), as well as in BRCA1-associated hereditary ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP385855.RAwScJUU_KEjZlbFpv98_noJW7tOeD7ZabrTaipQwlFhU130_provenance.